Post-transplant lymphoproliferative disorder in view of the new WHO classification: a more rational approach to a protean disease?

Multicenter Analysis of 80 Solid Organ Transplantation Recipients With Post-Transplantation Lymphoproliferative Disease: Outcomes and Prognostic Factors in the Modern Era

(2010) Andrew M. Evens et al.   JOURNAL OF CLINICAL ONCOLOGY

Impact of HLA Mismatching on Incidence of Posttransplant Non-Hodgkin Lymphoma After Kidney Transplantation

(2010) Gerhard Opelz et al.   TRANSPLANTATION

Treatment of PTLD with Rituximab and CHOP Reduces the Risk of Renal Graft Impairment after Reduction of Immunosuppression

(2009) R. Trappe et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Tumour necrosis factor gene polymorphism: a predictive factor for the development of post-transplant lymphoproliferative disease

(2009) K A McAulay et al.   BRITISH JOURNAL OF CANCER

EBV PCR in the Diagnosis and Monitoring of Posttransplant Lymphoproliferative Disorder: Results of a Two-Arm Prospective Trial

(2008) D. E. Tsai et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Epstein–Barr virus, rapamycin, and host immune responses

(2008) Sheri M Krams et al.   Current Opinion in Organ Transplantation

Adoptive cell therapy against EBV-related malignancies: a survey of clinical results

(2008) Anna Merlo et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

Peripheral T-cell lymphomas, unspecified (or not otherwise specified): a review

(2007) Delvys Rodriguez-Abreu et al.   HEMATOLOGICAL ONCOLOGY